CorMedix surged on strong DefenCath sales and a Melinta acquisition. I maintain a Sell rating on CRMD stock, citing ...
Owning 5 mutual funds doesn’t make you diversified. It might just mean you’re betting 5 times on the same 10 stocks and you’ll discover it only when all of them crash together.
ARCC remains a top-tier BDC with a strong track record, but I’m avoiding the recent dip and favoring KBDC instead. Read why I ...
Two-dimensional liquid chromatography (2D-LC) improves chromatographic performance, with LCxLC providing extensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback